Transgene Biotek Ltd

BSE: 526139

47

total announcements

TRABI.BO · 15 min delayed

Key Stats · Yahoo Finance · as of 21 Oct 2026

Market Cap

₹19 Cr

EPS (TTM)

₹-0.21

52W Low

₹1.83

52W High

₹4.34

Dividend Yield

0.00%

Beta

0.97

Price / Book

2.3

Debt / Equity

204.6

Revenue (TTM)

₹22,17,000.00

Gross Margin

99.91%

Operating Margin

-165.83%

Announcements Discussion

BSECompany UpdateAuditor Change23 Sept 2026

TRANSGENE BIOTEK LIMITED

TRANSGENE BIOTEK LIMITED has informed BSE about Resignation Details of Statutory Auditor. <p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr height="40" style="height: 30.0pt"> <td colspan="12" height="40" style="border: .5pt solid windowtext; " class="TTRow_left"> <a name="RANGE!D8">Resignation ....

Transgene Biotech Limited has informed the BSE about the resignation of its statutory auditor. The details of the resignation are not provided in the announcement.

BSECompany UpdateAuditor Change23 Sept 2026

TRANSGENE BIOTEK LIMITED

TRANSGENE BIOTEK LIMITED has informed BSE about Resignation Details of Statutory Auditor. <p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr height="40" style="height: 30.0pt"> <td colspan="12" height="40" style="border: .5pt solid windowtext; " class="TTRow_left"> <a name="RANGE!D8">Resignation ....

Transgene Biotech Limited has informed the BSE about the resignation of its statutory auditor.

BSECompany UpdateAuditor Change23 Sept 2026

TRANSGENE BIOTEK LIMITED

TRANSGENE BIOTEK LIMITED has informed BSE about Resignation Details of Statutory Auditor. <p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr height="40" style="height: 30.0pt"> <td colspan="12" height="40" style="border: .5pt solid windowtext; " class="TTRow_left"> <a name="RANGE!D8">Resignation ....

Transgene Biotech Limited has informed the BSE about the resignation of its statutory auditor.

BSECompany UpdateAuditor Change23 Sept 2026

TRANSGENE BIOTEK LIMITED

TRANSGENE BIOTEK LIMITED has informed BSE about Resignation Details of Statutory Auditor. <p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr height="40" style="height: 30.0pt"> <td colspan="12" height="40" style="border: .5pt solid windowtext; " class="TTRow_left"> <a name="RANGE!D8">Resignation ....

Transgene Biotech Limited has informed the BSE about the resignation of its statutory auditor.

BSECompany UpdateAuditor Change23 Sept 2026

TRANSGENE BIOTEK LIMITED

TRANSGENE BIOTEK LIMITED has informed BSE about Resignation Details of Statutory Auditor. <p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr height="40" style="height: 30.0pt"> <td colspan="12" height="40" style="border: .5pt solid windowtext; " class="TTRow_left"> <a name="RANGE!D8">Resignation ....

Transgene Biotech Limited has informed the BSE about the resignation of its statutory auditor.

BSECompany UpdateAuditor Change23 Sept 2026

TRANSGENE BIOTEK LIMITED

TRANSGENE BIOTEK LIMITED has informed BSE about Resignation Details of Statutory Auditor. <p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr height="40" style="height: 30.0pt"> <td colspan="12" height="40" style="border: .5pt solid windowtext; " class="TTRow_left"> <a name="RANGE!D8">Resignation ....

Transgene Biotech Limited has informed the BSE about the resignation of its statutory auditor.

BSECompany UpdateAuditor Change23 Sept 2026

TRANSGENE BIOTEK LIMITED

TRANSGENE BIOTEK LIMITED has informed BSE about Resignation Details of Statutory Auditor. <p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr height="40" style="height: 30.0pt"> <td colspan="12" height="40" style="border: .5pt solid windowtext; " class="TTRow_left"> <a name="RANGE!D8">Resignation ....

Transgene Biotech Limited has informed the BSE about the resignation details of its statutory auditor.

BSECompany UpdateAuditor Change23 Sept 2026

TRANSGENE BIOTEK LIMITED

TRANSGENE BIOTEK LIMITED has informed BSE about Resignation Details of Statutory Auditor. <p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr height="40" style="height: 30.0pt"> <td colspan="12" height="40" style="border: .5pt solid windowtext; " class="TTRow_left"> <a name="RANGE!D8">Resignation ....

Transgene Biotech Limited has informed the BSE about the resignation details of its statutory auditor.

BSECompany UpdateAuditor Change23 Sept 2026

TRANSGENE BIOTEK LIMITED

TRANSGENE BIOTEK LIMITED has informed BSE about Resignation Details of Statutory Auditor. <p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr height="40" style="height: 30.0pt"> <td colspan="12" height="40" style="border: .5pt solid windowtext; " class="TTRow_left"> <a name="RANGE!D8">Resignation ....

Transgene Biotech Limited has informed the BSE about the resignation of its statutory auditor.

BSECompany UpdateAuditor Change23 Sept 2026

TRANSGENE BIOTEK LIMITED

TRANSGENE BIOTEK LIMITED has informed BSE about Resignation Details of Statutory Auditor. <p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr height="40" style="height: 30.0pt"> <td colspan="12" height="40" style="border: .5pt solid windowtext; " class="TTRow_left"> <a name="RANGE!D8">Resignation ....

Transgene Biotech Limited has informed the BSE about the resignation details of its statutory auditor.

BSECompany UpdateAuditor Change23 Sept 2026

TRANSGENE BIOTEK LIMITED

TRANSGENE BIOTEK LIMITED has informed BSE about Resignation Details of Statutory Auditor. <p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr height="40" style="height: 30.0pt"> <td colspan="12" height="40" style="border: .5pt solid windowtext; " class="TTRow_left"> <a name="RANGE!D8">Resignation ....

Transgene Biotech Limited has informed the BSE about the resignation of its statutory auditor.

BSECompany UpdateAuditor Change23 Sept 2026

TRANSGENE BIOTEK LIMITED

TRANSGENE BIOTEK LIMITED has informed BSE about Resignation Details of Statutory Auditor. <p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr height="40" style="height: 30.0pt"> <td colspan="12" height="40" style="border: .5pt solid windowtext; " class="TTRow_left"> <a name="RANGE!D8">Resignation ....

Transgene Biotech Limited has informed the BSE about the resignation details of its statutory auditor.

BSECompany UpdateAuditor Change23 Sept 2026

TRANSGENE BIOTEK LIMITED

TRANSGENE BIOTEK LIMITED has informed BSE about Resignation Details of Statutory Auditor. <p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr height="40" style="height: 30.0pt"> <td colspan="12" height="40" style="border: .5pt solid windowtext; " class="TTRow_left"> <a name="RANGE!D8">Resignation ....

Transgene Biotech has informed BSE about the resignation of its statutory auditor.

BSECompany UpdateAuditor Change23 Sept 2026

TRANSGENE BIOTEK LIMITED

TRANSGENE BIOTEK LIMITED has informed BSE about Resignation Details of Statutory Auditor. <p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr height="40" style="height: 30.0pt"> <td colspan="12" height="40" style="border: .5pt solid windowtext; " class="TTRow_left"> <a name="RANGE!D8">Resignation ....

Transgene Biotech Limited has informed the BSE about the resignation of its statutory auditor.

BSECompany UpdateAuditor Change23 Sept 2026

TRANSGENE BIOTEK LIMITED

TRANSGENE BIOTEK LIMITED has informed BSE about Resignation Details of Statutory Auditor. <p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr height="40" style="height: 30.0pt"> <td colspan="12" height="40" style="border: .5pt solid windowtext; " class="TTRow_left"> <a name="RANGE!D8">Resignation ....

Transgene Biotech Limited has informed the BSE about the resignation of its statutory auditor. The details of the resignation are not provided in the announcement.

BSECompany UpdateAuditor Change23 Sept 2026

TRANSGENE BIOTEK LIMITED

TRANSGENE BIOTEK LIMITED has informed BSE about Resignation Details of Statutory Auditor. <p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr height="40" style="height: 30.0pt"> <td colspan="12" height="40" style="border: .5pt solid windowtext; " class="TTRow_left"> <a name="RANGE!D8">Resignation ....

Transgene Biotech Limited has informed the BSE about the resignation of its statutory auditor.

BSECompany UpdateAuditor Change23 Sept 2026

TRANSGENE BIOTEK LIMITED

TRANSGENE BIOTEK LIMITED has informed BSE about Resignation Details of Statutory Auditor. <p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr height="40" style="height: 30.0pt"> <td colspan="12" height="40" style="border: .5pt solid windowtext; " class="TTRow_left"> <a name="RANGE!D8">Resignation ....

Transgene Biotech Limited has informed the BSE about the resignation of its statutory auditor.

BSECompany UpdateAuditor Change23 Sept 2026

Transgene Biotek Ltd

Intimation of Resignation of Statutory Auditors-M/s. Vasavi & Co., Chartered Accountants (FRN:020965S).

Transgene Biotek Ltd has announced the resignation of its statutory auditors, M/s Vasavi & Co., due to pre-occupation with other assignments. The company will take necessary steps to appoint a new statutory auditor.

Read more →📎 1 attachment

BSEInsider Trading / SASTRegulatory22 Sept 2026

Transgene Biotek Ltd

Closure of Trading Window

Transgene Biotek Ltd has announced the closure of its trading window for all directors, KMPs, designated employees, and connected persons from October 1, 2026, until 48 hours after the declaration of its second-quarter financial results.

Read more →📎 1 attachment

BSEInsider Trading / SASTRegulatory22 Sept 2026

Transgene Biotek Ltd

Closure of Trading Window

Transgene Biotek Ltd has announced the closure of its trading window for all directors, KMPs, designated employees, and connected persons from October 1, 2026, until 48 hours after the declaration of its second-quarter financial results on September 30, 2026.

Read more →📎 1 attachment

← PreviousPage 2 of 3Next →